Christopher & Dana Reeve Foundation Hosts Educational Evening in Boston

Wednesday, June 16, 2010 General News J E 4
SHORT HILLS, N.J., June 15 The following is being released by the Christopher & Dana Reeve Foundation:

WHAT: The Christopher & Dana Reeve Foundation will host a wine and cheese reception sponsored by 180 Medical in Boston to share information about the Reeve Foundation's programs, including updates on recent progress in spinal cord research, news about the Reeve Foundation's plans in Boston, and the activities of the Piers Point Sailing Club, a former Reeve Foundation Quality of Life grants recipient. A brief question and answer session will follow speeches.

This is an excellent opportunity to learn how to get involved with the Reeve Foundation, as well as some of the spinal cord injury activities and quality of life initiatives in your own community.

Space is limited. There is a $25.00 registration fee. To attend, please register online at or call (800) 225-0292 for more information.

WHO: The following will be featured speakers at this event:

WHEN: Thursday, July 15th

6:30 to 8:30 p.m.

WHERE: Boston Marriott Long Wharf

296 State Street

Boston, MA 02109


About the Christopher & Dana Reeve Foundation

The Christopher and Dana Reeve Foundation is dedicated to curing spinal cord injury by funding innovative research, and improving the quality of life for people living with paralysis through grants, information and advocacy. For more information, please visit our website at or call 800-225-0292.

-- Peter T. Wilderotter, President and CEO, Christopher & Dana Reeve Foundation -- Susan Howley, Executive Vice President for Research, Christopher & Dana Reeve Foundation, nationally recognized for her leadership in the field of spinal cord research for the last 25 years -- Piers Point Sailing Club

SOURCE Christopher & Dana Reeve Foundation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
PDL BioPharma Provides Second Quarter 2010 Revenue...
FDA to Communicate Safety Monitoring Activities to...